Episode 7: Perceptive Advisors' Joe Edelman discusses how biotech investing has changed over his extensive career, and his thoughts on running an investment firm episode artwork

EPISODE · Jun 25, 2026 · 46 MIN

Episode 7: Perceptive Advisors' Joe Edelman discusses how biotech investing has changed over his extensive career, and his thoughts on running an investment firm

from Off-Target Effects with Matt Gline · host BiotechTV

He describes to Matt how the market has become more efficient since he started in the 1990's. He shares his perspective on single-asset vs pipeline companies, and today's M&A dynamic. Plus, his goal of being unbiased as an investor and how he tries to create an environment at Perceptive where that style is instilled in his analysts.

Episode metadata supplied by the publisher feed · Published Jun 25, 2026

Embed this episode

Ready to play

Episode 7: Perceptive Advisors' Joe Edelman discusses how biotech investing has changed over his extensive career, and his thoughts on running an investment firm

0:00 46:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Off-Target Effects with Matt Gline?

This episode is 46 minutes long.

When was this Off-Target Effects with Matt Gline episode published?

This episode was published on June 25, 2026.

Can I download this Off-Target Effects with Matt Gline episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!